27 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
extensive management time and focus. In addition, there is a natural transition period when a new CRO or supplier commences work. As a result, delays may
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
extensive management time and focus. In addition, there is a natural transition period when a new CRO or supplier commences work. As a result, delays
6-K
EX-99.3
rv427ea 8atyi07y14
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
6n9ed9bnxz3 329
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
1l1p5br pc
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
2c1e4wav5b1l9h5zn
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
8i4otf4fykx dq
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
xdnwqtff
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.1
zi25c2t79f0zh7ph
29 Jun 22
Current report (foreign)
9:58pm
20-F
ekladxdzxe6 1psva3
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-15.1
odn13mk6r r2rxh
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.21
p8l7udr 4dc5s6ob
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.22
zdtnrc1
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-11.1
ffc73f
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.23
f84 2932sw
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
tpp07a8gkncdggmr
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
310621qgk2ddx6ha5m
13 Apr 22
Consolidated Financial Statements
7:22am